{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:09Z","timestamp":1791348609972,"version":"4.3.1"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.smim.2026.102068","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:35:07Z","timestamp":1790922907000},"page":"102068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL-1 signaling in cancer-associated fibroblasts: shaping fibroblast heterogeneity, tumor immunity, and therapeutic resistance"],"prefix":"10.1016","volume":"84","author":[{"given":"Monica","family":"Gabola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Benzarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-9393","authenticated-orcid":false,"given":"Elisabeth","family":"Letellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2026.102068_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL -1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2026.102068_bib2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2019.01412","article-title":"Structural basis of IL-1 family cytokine signaling","volume":"10","author":"Fields","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102068_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071631","article-title":"Interleukin expression after injury and the effects of interleukin-1 receptor antagonist","volume":"8","author":"Chamberlain","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.smim.2026.102068_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41423-025-01358-8","article-title":"IL-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2026.102068_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Sig Transduct. Target. Ther."},{"key":"10.1016\/j.smim.2026.102068_bib8","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","article-title":"Differential requirement for the activation of the inflammasome for processing and release of IL-1\u03b2 in monocytes and macrophages","volume":"113","author":"Netea","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102068_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1091\/mbc.10.5.1463","article-title":"The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles","volume":"10","author":"Andrei","year":"1999","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.smim.2026.102068_bib10","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1073\/pnas.0308558101","article-title":"Phospholipases C and A2 control lysosome-mediated IL-1\u03b2 secretion: Implications for inflammatory processes","volume":"101","author":"Andrei","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2026.102068_bib11","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.179.3.1913","article-title":"Nonclassical IL-1\u03b2 Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages","volume":"179","author":"Qu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102068_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ni.3503","article-title":"Interleukin 1\u03b1 and the inflammatory process","volume":"17","author":"Di Paolo","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/eji.1830270139","article-title":"A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling","volume":"27","author":"Korherr","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The Interleukin-1 Family: Back to the Future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102068_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1074\/mcp.M600455-MCP200","article-title":"Mass Spectrometric Analysis of the Endogenous Type I Interleukin-1 (IL-1) Receptor Signaling Complex Formed after IL-1 Binding Identifies IL-1RAcP, MyD88, and IRAK-4 as the Stable Components","volume":"6","author":"Brikos","year":"2007","journal-title":"Mol. & Cell. Proteom."},{"key":"10.1016\/j.smim.2026.102068_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor\u2013dependent responses by IRAK1 and IRAK2","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/383443a0","article-title":"TRAF6 is a signal transducer for interleukin-1","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102068_bib19","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig Transduct. Target. Ther."},{"key":"10.1016\/j.smim.2026.102068_bib20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","article-title":"Tumor necrosis factor receptor-associated factor regulation of nuclear factor \u03baB and mitogen-activated protein kinase pathways","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib21","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e21","article-title":"IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance","volume":"24","author":"Kim","year":"2024","journal-title":"Immune Netw."},{"key":"10.1016\/j.smim.2026.102068_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation","volume":"32","author":"Peters","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.smim.2026.102068_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.32604\/biocell.2023.025850","article-title":"M. Interleukin-1 receptor antagonist: From synthesis to therapeutic applications","volume":"47","author":"Rehman","year":"2023","journal-title":"BIOCELL"},{"key":"10.1016\/j.smim.2026.102068_bib25","article-title":"Interleukin-1 (IL-1)","volume":"3","author":"Weber","year":"2010","journal-title":"Pathw. Sci. Signal."},{"key":"10.1016\/j.smim.2026.102068_bib26","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds That Do Not Heal","volume":"315","author":"Flier","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102068_bib27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3389\/fimmu.2019.02178","article-title":"Tumors vs. Chronic Wounds: An Immune Cell\u2019s Perspective","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib29","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","article-title":"Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment","volume":"25","author":"Tulotta","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib30","article-title":"Cancer\u2011associated fibroblast stimulates cancer cell invasion in an interleukin\u20111 receptor (IL\u20111R)\u2011dependent manner","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.smim.2026.102068_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib32","first-page":"269","article-title":"The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression","volume":"23","author":"Pantschenko","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib33","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.1202769","article-title":"The Role of IL-1\u03b2 in the Early Tumor Cell\u2013Induced Angiogenic Response","volume":"190","author":"Carmi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163802","article-title":"A paracrine circuit of IL-1\u03b2\/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression","volume":"133","author":"Chen","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.smim.2026.102068_bib35","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: Origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102068_bib36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/biom13060945","article-title":"Fibroblasts\u2014Warriors at the intersection of wound healing and disrepair","volume":"13","author":"Roman","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.smim.2026.102068_bib37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/bioengineering11121188","article-title":"Human Skin Fibroblasts as an In Vitro Model Illustrating Changes in Collagen Levels and Skin Cell Migration Under the Influence of Selected Plant Hormones","volume":"11","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.smim.2026.102068_bib38","first-page":"317","article-title":"Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation","volume":"151","author":"Smith","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2026.102068_bib39","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1038\/s41467-026-70842-0","article-title":"FGFR signaling establishes spatial gradients of secretory cell identities along the airway proximal-distal axis","volume":"17","author":"Sountoulidis","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jid.2016.11.035","article-title":"Dermal Fibroblasts Promote Alternative Macrophage Activation Improving Impaired Wound Healing","volume":"137","author":"Ferrer","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.smim.2026.102068_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.tcb.2023.03.007","article-title":"The diverse nature of intestinal fibroblasts in development, homeostasis, and disease","volume":"33","author":"Br\u00fcgger","year":"2023","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41556-025-01638-5","article-title":"Effects of embryonic origin, tissue cues and pathological signals on fibroblast diversity in humans","volume":"27","author":"Torregrossa","year":"2025","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.devcel.2020.02.003","article-title":"Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development","volume":"52","author":"Rao-Bhatia","year":"2020","journal-title":"Dev. Cell."},{"key":"10.1016\/j.smim.2026.102068_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001032","article-title":"Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis","volume":"18","author":"Br\u00fcgger","year":"2020","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib45","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/cells10112840","article-title":"Fibroblast Memory in Development, Homeostasis and Disease","volume":"10","author":"Kirk","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.smim.2026.102068_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924866","article-title":"Fibroblasts in intestinal homeostasis, damage, and repair","volume":"13","author":"Chalkidi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib47","first-page":"120","article-title":"Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor \u03b2 Receptor (TGF\u03b2R)","volume":"13","author":"Cheng","year":"2024","journal-title":"F1000Res"},{"key":"10.1016\/j.smim.2026.102068_bib48","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","article-title":"IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer","volume":"14","author":"Koncina","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib49","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41388-020-01424-7","article-title":"Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis","volume":"39","author":"Cho","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.smim.2026.102068_bib50","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/cells13242058","article-title":"The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice","volume":"13","author":"Russo","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.smim.2026.102068_bib51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12964-025-02516-1","article-title":"Cancer-associated fibroblasts: central players in cancer hallmarks and therapeutic resistance","volume":"23","author":"Lu","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.smim.2026.102068_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer\u2014Then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102068_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/2010\/695162","article-title":"Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors","volume":"33","author":"Jotzu","year":"2010","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.smim.2026.102068_bib55","first-page":"863","article-title":"Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin","volume":"5","author":"McDonald","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.smim.2026.102068_bib56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.32193","article-title":"search of definitions: Cancer-associated fibroblasts and their markers","volume":"146","author":"Nurmik","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102068_bib58","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/ijms17122142","article-title":"Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis","volume":"17","author":"Tellez-Gabriel","year":"2016","journal-title":"IJMS"},{"key":"10.1016\/j.smim.2026.102068_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","article-title":"Method of the Year: spatially resolved transcriptomics","volume":"18","author":"Marx","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.smim.2026.102068_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14348\/molcells.2023.0009","article-title":"Integration of Single-Cell RNA-Seq Datasets: A Review of Computational Methods","volume":"46","author":"Ryu","year":"2023","journal-title":"Mol. Cells"},{"key":"10.1016\/j.smim.2026.102068_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell. Syst."},{"key":"10.1016\/j.smim.2026.102068_bib62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13046-023-02934-4","article-title":"Transcription factors in fibroblast plasticity and CAF heterogeneity","volume":"42","author":"Melchionna","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib63","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102068_bib65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.smim.2026.102068_bib66","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.smim.2026.102068_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib68","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.smim.2026.102068_bib69","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib70","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib71","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","article-title":"miR200-regulated CXCL12\u03b2 promotes fibroblast heterogeneity and immunosuppression in ovarian cancers","volume":"9","author":"Givel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib73","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.smim.2026.102068_bib74","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","article-title":"Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer","volume":"15","author":"Croizer","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1516","article-title":"The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. &amp Transl. Med."},{"key":"10.1016\/j.smim.2026.102068_bib76","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","article-title":"Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy","volume":"15","author":"Forsthuber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2025.102601","article-title":"Cancer-associated fibroblasts: Recent advances and therapeutic implications","volume":"98","author":"Paraskeva","year":"2026","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib78","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1158\/0008-5472.CAN-22-2316","article-title":"Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines","volume":"83","author":"Schw\u00f6rer","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and Biology of Cancer-Associated Fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.smim.2026.102068_bib80","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.3390\/ijms21176009","article-title":"Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.smim.2026.102068_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2011.12.006","article-title":"KrasG12D-Induced IKK2\/\u03b2\/NF-\u03baB Activation by IL-1\u03b1 and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma","volume":"21","author":"Ling","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41389-022-00434-2","article-title":"Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer","volume":"11","author":"Mello","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.smim.2026.102068_bib83","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/0008-5472.CAN-24-2330","article-title":"SMAD4 and KRAS Status Shapes Cancer Cell\u2013Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer","volume":"85","author":"Lloyd","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","author":"Muz","year":"2015","journal-title":"HP"},{"key":"10.1016\/j.smim.2026.102068_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1438","article-title":"Hypoxic microenvironment determines the phenotypic plasticity and spatial distribution of cancer-associated fibroblasts","volume":"13","author":"Choi","year":"2023","journal-title":"Clin. & Transl. Med."},{"key":"10.1016\/j.smim.2026.102068_bib86","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/stem.3455","article-title":"ELF3 Mediates IL -1\u03b1 Induced Differentiation of Mesenchymal Stem Cells to Inflammatory iCAFs","volume":"39","author":"Tran","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.smim.2026.102068_bib87","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/ijms22094960","article-title":"The Blockade of Tumoral IL1\u03b2-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation","volume":"22","author":"D\u00edaz-Maroto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2026.102068_bib88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10120-022-01352-3","article-title":"IL-1\u03b2 derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment","volume":"26","author":"Zhang","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116849","article-title":"NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"45","author":"Guo","year":"2026","journal-title":"Cell. Rep."},{"key":"10.1016\/j.smim.2026.102068_bib90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102068_bib91","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78921","article-title":"Neutrophil-mediated fibroblast-tumor cell il-6\/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study","volume":"11","author":"De Castro Silva","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.smim.2026.102068_bib92","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/s41467-019-12370-8","article-title":"NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis","volume":"10","author":"Ershaid","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib93","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1038\/s44318-025-00542-w","article-title":"Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer","volume":"44","author":"Karta","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2026.102068_bib94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ags3.70116","article-title":"Intratumoral Fusobacterium nucleatum Drives Cancer-Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma","volume":"10","author":"Ofuchi","year":"2026","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.smim.2026.102068_bib95","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12935-025-04023-2","article-title":"Fusobacterium nucleatum increases CTGF expression through TLR2-YAP signaling axis in cancer-associated fibroblasts, thereby promoting colorectal cancer progression","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.smim.2026.102068_bib96","article-title":"Preprint at","author":"Lisek","year":"2025","journal-title":"Spatiotemporal Dyn. Tumor Microenviron. Remodel."},{"key":"10.1016\/j.smim.2026.102068_bib97","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1038\/s41467-025-58748-9","article-title":"Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression","volume":"16","author":"Harada","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-021-00302-5","article-title":"TGF-\u03b21-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.smim.2026.102068_bib99","doi-asserted-by":"crossref","first-page":"28","DOI":"10.36922\/CP025310046","article-title":"Interleukin-1 beta signaling in cancer: A double-edged sword in inflammation and tumorigenesis","volume":"7","author":"Yilmaz","year":"2025","journal-title":"CP"},{"key":"10.1016\/j.smim.2026.102068_bib100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nri.2017.89","article-title":"Synthetic immune niches for cancer immunotherapy","volume":"18","author":"Weiden","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64839-4","article-title":"Cancer cell-derived IL-1\u03b2 reverses chemo-immunotherapy resistance in non-small cell lung cancer","volume":"16","author":"Perrichet","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib102","first-page":"767","article-title":"Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors","volume":"77","author":"Nakamura","year":"1986","journal-title":"Jpn J. Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib103","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1084\/jem.168.6.2031","article-title":"Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity","volume":"168","author":"North","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102068_bib104","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102068_bib105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib106","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1039763","article-title":"Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells","volume":"5","author":"Haabeth","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.smim.2026.102068_bib107","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.trecan.2025.04.012","article-title":"The plasticity of cancer-associated fibroblasts","volume":"11","author":"Xia","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib108","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009523","article-title":"Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment","volume":"12","author":"Hansen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib109","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib110","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/1535-7163.MCT-21-0083","article-title":"Targeting Tumor\u2013Stromal IL6\/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer","volume":"20","author":"Dosch","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.smim.2026.102068_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013175","article-title":"Oncolytic virus-induced IL-1\u03b2+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer","volume":"13","author":"Li","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib112","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00262-025-04138-5","article-title":"IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer","volume":"74","author":"Lang","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.smim.2026.102068_bib113","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00262-022-03277-3","article-title":"Blockade of IL-1\u03b1 and IL-1\u03b2 signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy","volume":"72","author":"Rydberg Millrud","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.smim.2026.102068_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2022.07.006","article-title":"Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment","volume":"67","author":"Xiang","year":"2022","journal-title":"Cytokine & Growth Factor. Rev."},{"key":"10.1016\/j.smim.2026.102068_bib115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12032-024-02422-5","article-title":"Interleukin-6 serves as a critical factor in various cancer progression and therapy","volume":"41","author":"Mohamed","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib116","doi-asserted-by":"crossref","first-page":"65982","DOI":"10.18632\/oncotarget.11786","article-title":"Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells","volume":"7","author":"Nagathihalli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.smim.2026.102068_bib117","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2016.03.010","article-title":"Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival","volume":"151","author":"W\u00f6rmann","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2026.102068_bib118","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3390\/biomedicines13122966","article-title":"An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment","volume":"13","author":"Mei","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.smim.2026.102068_bib119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-019-0521-4","article-title":"The IL-1\/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer","volume":"7","author":"Brunetto","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/biology14060604","article-title":"Precision Medicine: IL-1RA and Pancreatic Cancer Organoids","volume":"14","author":"Morgan","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.smim.2026.102068_bib121","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.ymthe.2022.06.010","article-title":"An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ","volume":"30","author":"Ye","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.smim.2026.102068_bib122","author":"Hanschmann","year":"2026","journal-title":"IL-1\u03b1 Drives a Tumor-Strom. -neutrophil axis Inflamm. fibroblast Act. Head. neck Cancer Prepr."},{"key":"10.1016\/j.smim.2026.102068_bib123","first-page":"1","article-title":"Neutrophils in the Tumor Microenvironment","volume":"1224","author":"Wu","year":"2020"},{"key":"10.1016\/j.smim.2026.102068_bib124","doi-asserted-by":"crossref","first-page":"22212","DOI":"10.1074\/jbc.M115.644823","article-title":"Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis","volume":"290","author":"Mar","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2026.102068_bib125","article-title":"IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 Stability","volume":"7","author":"Zhang","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.smim.2026.102068_bib126","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00535-025-02273-5","article-title":"Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma","volume":"60","author":"Zhang","year":"2025","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.smim.2026.102068_bib127","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00011-018-1145-8","article-title":"A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells","volume":"67","author":"Yi","year":"2018","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.smim.2026.102068_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156161","article-title":"The role of interleukin -1 family in fibrotic diseases","volume":"165","author":"Wang","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2026.102068_bib129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1159\/000524560","article-title":"IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19","volume":"14","author":"Renieris","year":"2022","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.smim.2026.102068_bib130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.169.1.469","article-title":"Proinflammatory Cytokine IL-1\u03b2 Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction","volume":"169","author":"Saijo","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib131","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2\u2013expressing macrophages is a prerequisite for IL-1\u03b2\u2013induced neovascularization and tumor growth","volume":"115","author":"Nakao","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2026.102068_bib132","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","article-title":"Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment","volume":"55","author":"Gong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102068_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1515390","article-title":"Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity","volume":"16","author":"Mentucci","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102068_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-025-02575-4","article-title":"IL-1\u03b2-mediated suppression of CIITA attenuates IFN-\u03b3-induced MHC-II expression on Fibroblasts","volume":"24","author":"Chen","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.smim.2026.102068_bib135","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1073\/pnas.1812266115","article-title":"Blocking IL-1\u03b2 reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation","volume":"116","author":"Kaplanov","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102068_bib136","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2015.07.044","article-title":"Tumor microenvironment and cancer therapy resistance","volume":"380","author":"Sun","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.smim.2026.102068_bib137","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1038\/s41467-021-26407-4","article-title":"Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy","volume":"12","author":"Bent","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib138","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102068_bib139","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2015.03.008","article-title":"Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin \u03b21\/FAK Signaling","volume":"27","author":"Hirata","year":"2015","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib140","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102068_bib141","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3892\/mmr.2016.4868","article-title":"Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.smim.2026.102068_bib142","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/genes17050527","article-title":"Transcriptomic Insights into the Association of IL-1 Signaling with the Senescence-Associated Secretory Phenotype in Human Fibroblasts","volume":"17","author":"Yilmaz","year":"2026","journal-title":"Genes"},{"key":"10.1016\/j.smim.2026.102068_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1083743","article-title":"IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy","volume":"10","author":"Romaniello","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib144","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1073\/pnas.0905299106","article-title":"Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6\/IL-8 cytokine network","volume":"106","author":"Orjalo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102068_bib145","doi-asserted-by":"crossref","first-page":"e00586","DOI":"10.1128\/MCB.00586-18","article-title":"Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role","volume":"39","author":"Lau","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102068_bib146","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-24-1185","article-title":"Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma","volume":"85","author":"Ou","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib147","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.smim.2026.102068_bib148","doi-asserted-by":"crossref","first-page":"eadj5705","DOI":"10.1126\/scitranslmed.adj5705","article-title":"TSPAN8+ myofibroblastic cancer\u2013associated fibroblasts promote chemoresistance in patients with breast cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2026.102068_bib149","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1158\/0008-5472.CAN-25-0766","article-title":"PI3K and MAPK Signaling Nodes Serve as Divergent Drivers of Phenotypic Plasticity in Cancer-Associated Fibroblasts in Colorectal Cancer","volume":"86","author":"Xia","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54975-8","article-title":"Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer","volume":"15","author":"Veghini","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib151","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","article-title":"Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib152","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.43384","article-title":"Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study","volume":"78","author":"Eviatar","year":"2026","journal-title":"Arthritis & Rheumatol."},{"key":"10.1016\/j.smim.2026.102068_bib153","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/cancers13030477","article-title":"Therapeutic Strategies for Targeting IL-1 in Cancer","volume":"13","author":"Gottschlich","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.smim.2026.102068_bib154","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","article-title":"Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1\u03b2-Induced Interleukin 6 Production and the Myeloma Proliferative Component","volume":"84","author":"Lust","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.smim.2026.102068_bib155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.24352","article-title":"Reduction in C-reactive protein indicates successful targeting of the IL-1\/IL-6 axis resulting in improved survival in early stage multiple myeloma","volume":"91","author":"Lust","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.smim.2026.102068_bib156","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib157","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10637-015-0226-6","article-title":"Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer","volume":"33","author":"Hong","year":"2015","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.smim.2026.102068_bib158","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102068_bib159","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2026.102068_bib160","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.23.00910","article-title":"Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial","volume":"42","author":"Garon","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107451","volume":"189","author":"Paz-Ares","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.smim.2026.102068_bib162","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.23.00980","article-title":"Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial","volume":"42","author":"Tan","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib163","article-title":"CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC","volume":"6","author":"Lee","year":"2025","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.smim.2026.102068_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2025.0288","article-title":"Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment","author":"Shen","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.smim.2026.102068_bib165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/ITT.S291767","article-title":"Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma","volume":"10","author":"Bughda","year":"2021","journal-title":"ITT"},{"key":"10.1016\/j.smim.2026.102068_bib166","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/2767-9764.CRC-24-0490","article-title":"The Impact of the Tumor Microenvironment on the Effect of IL-1\u03b2 Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials","volume":"5","author":"Solomon","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.smim.2026.102068_bib167","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib168","article-title":"Insights into the relevance of targeting fibroblasts to control cancer","volume":"6","author":"Boeker","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.smim.2026.102068_bib169","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1038\/s41388-021-01866-7","article-title":"\u03b1SMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression","volume":"40","author":"McAndrews","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.smim.2026.102068_bib170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: Perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102068_bib171","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13058-025-02183-7","article-title":"Spatial and temporal dynamics of cancer-associated fibroblast niches in breast cancer","volume":"28","author":"Pantaleo","year":"2026","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.smim.2026.102068_bib172","article-title":"Crosstalk Between Cancer-Associated Fibroblasts and Immune Cells: Mechanisms and Therapeutic Implications","volume":"4","author":"Li","year":"2025","journal-title":"MedComm. Oncol."},{"key":"10.1016\/j.smim.2026.102068_bib173","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/nm.3646","article-title":"A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer","volume":"20","author":"Sch\u00f6nhuber","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102068_bib174","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm559","article-title":"Cre reconstitution allows for DNA recombination selectively in dual-marker-expressing cells in transgenic mice","volume":"35","author":"Xu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.smim.2026.102068_bib175","author":"Yoshihara","year":"2026","journal-title":"APOC1+ Inflamm. CAF- State Drives a senescent Treat. -Resist. niche Rheum. Arthritis"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:30Z","timestamp":1791345270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":175,"alternative-id":["S1044532326000552"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102068","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1 signaling in cancer-associated fibroblasts: shaping fibroblast heterogeneity, tumor immunity, and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102068"}}